Stage IV Renal Cell Cancer
Showing 1 - 25 of 61
Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer Trial in New Brunswick (Arterial Spin
Completed
- Stage I Renal Cell Cancer
- +3 more
- Arterial Spin Labeling Magnetic Resonance Imaging
- +3 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Oct 14, 2022
Advanced Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Seattle (Aldesleukin,
Recruiting
- Advanced Clear Cell Renal Cell Carcinoma
- +3 more
- Aldesleukin
- Pembrolizumab
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 5, 2022
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Buffalo, Rochester
Terminated
- Clear Cell Renal Cell Carcinoma
- +3 more
- panobinostat
- +7 more
-
Buffalo, New York
- +1 more
Aug 11, 2022
Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Cancer, Recurrent Renal Cell Carcinoma Trial in United States
Active, not recruiting
- Clear Cell Renal Cell Carcinoma
- +3 more
- Anti-OX40 Antibody PF-04518600
- +3 more
-
Los Angeles, California
- +9 more
Aug 5, 2022
Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Buffalo (radiation, procedure, other)
Completed
- Recurrent Renal Cell Cancer
- Stage IV Renal Cell Cancer
- stereotactic body radiation therapy
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 20, 2022
Diarrhea, Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Duarte (other, dietary supplement, drug)
Active, not recruiting
- Diarrhea
- +2 more
- Laboratory Biomarker Analysis
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 7, 2022
Metastatic Renal Cell Cancer, Recurrent Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Chicago (Stereotactic Body
Recruiting
- Metastatic Renal Cell Cancer
- +2 more
- Stereotactic Body Radiation Therapy
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Jun 3, 2022
Metastatic Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Sacramento (Ibrutinib, Nivolumab)
Completed
- Metastatic Renal Cell Cancer
- Stage IV Renal Cell Cancer
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Feb 8, 2022
Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker
Active, not recruiting
- Acute Myeloid Leukemia
- +66 more
- Best Practice
- +3 more
-
Fullerton, CaliforniaVirginia K Crosson Cancer Center
Jan 31, 2022
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Rochester, Madison (CCI-779,
Completed
- Clear Cell Renal Cell Carcinoma
- +2 more
-
Rochester, Minnesota
- +1 more
Jan 12, 2022
Recurrent Malignant Solid Tumor, Stage IV Breast Cancer, Stage IV Prostate Cancer Trial in Washington (Canady Helios Cold Plasma
Active, not recruiting
- Recurrent Malignant Solid Neoplasm
- +15 more
- Canady Helios Cold Plasma Scalpel
-
Washington, District of ColumbiaCanady Surgical Group PC
Jul 16, 2021
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Los Angeles
Completed
- Clear Cell Renal Cell Carcinoma
- +2 more
- AdGMCAIX-transduced autologous dendritic cells
- +2 more
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center
Jul 28, 2021
Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Bronx, New York (vorinostat,
Terminated
- Recurrent Renal Cell Cancer
- +2 more
-
Bronx, New York
- +1 more
Feb 1, 2021
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +44 more
- fludarabine phosphate
- +9 more
-
Duarte, California
- +6 more
Sep 6, 2019
Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in United States (drug, radiation, procedure, biological, other)
Completed
- Recurrent Renal Cell Cancer
- Stage IV Renal Cell Cancer
- fludarabine phosphate
- +7 more
-
Tucson, Arizona
- +5 more
Jul 23, 2019
Magnetic Resonance Imaging in Predicting Response to Sunitinib
Completed
- Renal Cell Carcinoma
- +2 more
- mutation analysis
- +5 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of The University of Pennsylvania
Jun 21, 2019
Advanced Malignant Tumor, Cervical Squamous Cell Carcinoma, Endometrial Carcinoma Trial in Scottsdale, Rochester (Laboratory
Completed
- Advanced Malignant Neoplasm
- +31 more
- Laboratory Biomarker Analysis
- +2 more
-
Scottsdale, Arizona
- +1 more
Jun 5, 2019
Recurrent Renal Cell Carcinoma, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in United States (Erlotinib
Completed
- Recurrent Renal Cell Carcinoma
- +4 more
- Erlotinib Hydrochloride
- +2 more
-
Tucson, Arizona
- +213 more
Dec 12, 2018
B-Cell Tumor, Estrogen Receptor Negative, HER2/Neu Negative Trial in Stanford (18F-FSPG, 18F-FDG)
Completed
- B-Cell Neoplasm
- +15 more
-
Stanford, CaliforniaStanford University Medical Center
Dec 11, 2018
Fatigue, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Cleveland (procedure, other, drug)
Terminated
- Fatigue
- +2 more
- transcranial magnetic stimulation
- +3 more
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Nov 14, 2018
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Houston (procedure, drug,
Terminated
- Clear Cell Renal Cell Carcinoma
- +2 more
- therapeutic conventional surgery
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 22, 2018
Stage IV Renal Cell Cancer Trial in Berlin, Bonn, Hannover (MGN1601)
Completed
- Stage IV Renal Cell Cancer
- MGN1601
-
Berlin, Germany
- +2 more
Nov 13, 2018
Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Cleveland (sunitinib malate)
Completed
- Clear Cell Renal Cell Carcinoma
- Stage IV Renal Cell Cancer
- sunitinib malate
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Aug 17, 2018
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Australia, Taiwan, United
Completed
- Clear Cell Renal Cell Carcinoma
- +4 more
- Anti-Endoglin Chimeric Monoclonal Antibody TRC105
- +3 more
-
Duarte, California
- +29 more
Jul 30, 2018
Recurrent Melanoma, Recurrent Pancreatic Cancer, Recurrent Renal Cell Cancer Trial in Winston-Salem (siRNA-transfected
Completed
- Recurrent Melanoma
- +11 more
- siRNA-transfected peripheral blood mononuclear cells APN401
- laboratory biomarker analysis
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Jul 2, 2018